Carregant...

CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy

Molecularly, breast cancer represents a highly heterogenous family of neoplastic disorders, with substantial interpatient variations regarding genetic mutations, cell composition, transcriptional profiles, and treatment response. Consequently, there is an increasing demand for alternative diagnostic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Biosyst
Autors principals: Mintz, Rachel L., Gao, Madeleine A., Lo, Kahmun, Lao, Yeh-Hsing, Li, Mingqiang, Leong, Kam W.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7437870/
https://ncbi.nlm.nih.gov/pubmed/32832592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adbi.201800132
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!